Sirio Pharma (300791) — Financial Flexibility Index
Sirio Pharma (300791) has a Financial Flexibility Index of 0.09x as of June 2023. Free cash flow of CN¥161.25 Million (operating CF CN¥101.61 Million minus capex CN¥59.65 Million) represents 0% of total liabilities (CN¥1.85 Billion). Check 300791 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Sirio Pharma Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Sirio Pharma across 9 annual periods. See working capital position of Sirio Pharma to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Sirio Pharma (2016–2024)
Year-by-year free cash flow to debt coverage for Sirio Pharma. For the full company profile including market capitalisation, see Sirio Pharma stock valuation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.34x | CN¥979.10 Million | CN¥566.97 Million | CN¥2.84 Billion | ▲ +8.0% |
| 2023 | 0.32x | CN¥837.79 Million | CN¥386.08 Million | CN¥2.63 Billion | ▼ -36.0% |
| 2022 | 0.50x | CN¥738.55 Million | CN¥444.86 Million | CN¥1.48 Billion | ▼ -26.7% |
| 2021 | 0.68x | CN¥866.06 Million | CN¥341.38 Million | CN¥1.28 Billion | ▼ -41.6% |
| 2020 | 1.16x | CN¥542.72 Million | CN¥319.57 Million | CN¥466.95 Million | ▲ +20.7% |
| 2019 | 0.96x | CN¥398.50 Million | CN¥231.60 Million | CN¥414.01 Million | ▲ +72.9% |
| 2018 | 0.56x | CN¥422.78 Million | CN¥183.46 Million | CN¥759.53 Million | ▲ +88.3% |
| 2017 | 0.30x | CN¥209.18 Million | CN¥49.35 Million | CN¥707.58 Million | ▲ +1250.8% |
| 2016 | -0.03x | CN¥-25.61 Million | CN¥-98.26 Million | CN¥997.00 Million | — |